048410.KQ KOE
Hyundai Bioscience Co., Ltd.
1W: +2.9%
1M: +10.3%
3M: -15.4%
YTD: -39.0%
1Y: +21.6%
3Y: -41.2%
5Y: -62.5%
₩7,050.00 ($5.24)
+0.00 (+0.00%)
Weekly Expected Move ±9.4%
₩5720
₩6385
₩7050
₩7715
₩8380
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$17.4B
-870.7% ▼
Capital Expenditures
$1.2B
+45.0% ▲
5Y CAGR: -45.7%
Free Cash Flow
-$18.6B
-21349.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$18.7B
+912.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$20.1B | -$15.8B | -$14.5B | -$6.9B | -$22.1B |
| Depreciation & Amort. | $2.7B | $1.8B | $1.4B | $640M | $1.3B |
| Stock-Based Comp. | $578M | $0 | $0 | -$78M | $0 |
| Change in Working Capital | $5.5B | $1.4B | $1.1B | $180M | -$1.8B |
| Other Non-Cash Items | $10.8B | -$4.0B | $5.9B | $8.4B | $5.2B |
| Operating Cash Flow | -$538M | -$16.5B | -$6.0B | $2.3B | -$17.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$3.8B | -$1.5B | -$588M | -$170M | -$20.2B |
| Acquisitions (Net) | $0 | $13.2B | $0 | -$26.9B | $0 |
| Investment Purchases | -$13.0B | -$3.0B | $0 | $0 | -$32.0B |
| Investment Sales | $1.8B | $13.2B | $6.0B | $10.0B | $12.2B |
| Other Investing | $2.6B | -$13.3B | -$235M | -$2.6B | $1.4B |
| Investing Cash Flow | -$12.4B | $8.5B | $5.2B | -$19.7B | -$38.6B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$833M | -$1.3B | -$611M | $19.6B | -$9.1B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$622M | -$583M | -$541M | -$551M | -$414M |
| Financing Cash Flow | $3.0B | $1.7B | -$58M | $19.2B | $74.7B |
| Net Change in Cash | -$10.0B | -$6.5B | -$921M | $1.8B | $18.7B |
| Cash End of Period | $9.2B | $2.7B | $1.8B | $3.7B | $22.3B |
| Free Cash Flow | -$4.5B | -$18.3B | -$6.6B | $87M | -$18.6B |